【藥物發現】《BlueRock》與《bit.bio》攜手研發「iPSC衍生調節型T細胞(Treg) 」新藥

 【藥物發現】《BlueRock》與《bit.bio》攜手研發「iPSC衍生調節型T細胞(Treg) 」治療藥物

▌文章出處

 Live5news

▌原文標題

 BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies

▌Twitter

 https://twitter.com/aimedadviser/status/1689077900463804416

▌文章序號

 4008

｜智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.